XBIO Stock Catalyst: Xenetic Biosciences Reports Second Quarter 2026 Financial Results

Aug 7, 2026 · 8:35am ET

Company highlights strengthened scientific foundation for DNase platform.

Max move

+30.3%

High of day $3.83

Sparker timei

8:35am ET

XBIO · Aug 7, 2026

CATALYST DATE · 1-MINUTE BARS

Catalyst Summary

Xenetic Biosciences, Inc. (Nasdaq: XBIO) reported its financial results for the second quarter of 2026 on August 7, 2026. The company also highlighted the strengthened scientific foundation supporting the continued advancement of its proprietary DNase platform.

The announcement was made via an 8-K filing with the SEC. No specific financial figures were disclosed in the brief.

This summary was generated by AI from public sources and may contain errors. Not financial advice. Trade at your own risk.

Real-time alerts

Get notified the next time XBIO sparks.

Download Sniper App →

Catch the next XBIO-style move in real time.

Day Trader Sniper alerts you the moment a setup like this triggers: premarket, open, or intraday.

Watch demo Download Free →